MRNA vaccine technology faces growing doubts among state and federal lawmakers. The opposition comes at a critical juncture ...

The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...

Christopher Ridley, a spokesperson for Moderna, said the state legislative efforts are largely a product of ...

On the five-year anniversary of the Covid pandemic, a Times reporter, Apoorva Mandavilli, looks back at the success of, and the backlash to, the mRNA vaccine. There’s no question that this vaccine ...

COVID-19 vaccines made by Pfizer and Moderna are both mRNA vaccines, which teach the body to recognize and fight off the ...

Vaccine skeptics have long-since leveraged the rapid roll out of mRNA vaccines to add fuel to heated arguments surrounding ...

Some of terminated grants focused on boosting uptake in minority populations, with the cuts covering a range of vaccines.

A new study from Memorial Sloan Kettering Cancer Center has shown that an RNA-based neoantigen vaccine can generate ...

The updated mRNA-1273.815 COVID-19 vaccine was significantly protective against hospitalization and medically attended outcomes among adults in the United States.

Vaccine hesitancy and higher rates of school vaccine exemptions increases the risk of outbreaks of preventable diseases, creating a significant health risk for vulnerable populations.

One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...

On the five-year anniversary of the Covid pandemic, a Times reporter, Apoorva Mandavilli, looks back at the success of, and the backlash to, the mRNA vaccine. There’s no question that this ...